Alemtuzumab versus anti‐thymocyte globulin in kidney transplant recipients receiving a rapid steroid withdrawal regimen

Documenti analoghi

• Outcomes of older Black renal transplant recipients receiving basiliximab induction and early steroid withdrawal
  di: Sarah E Bova, et al.
  Pubblicazione: (2024)
• Alemtuzumab induction is associated with decreased hospitalization rates in pediatric kidney transplant: A UNOS data review for safety and outcomes with common induction regimens
  di: Emmanuel Aydin‐Ghormoz, et al.
  Pubblicazione: (2024)
• Adrenal insufficiency in pediatric kidney transplantation recipients
  di: Hyunwoong Harry Chae, et al.
  Pubblicazione: (2024)
• How to choose a best kidney for pediatric kidney transplant recipients
  di: Asha Moudgil, et al.
  Pubblicazione: (2024)
• Epidemiology and outcomes associated with enterococcal blood stream infection among liver and kidney transplant recipients
  di: Kevin D. He, et al.
  Pubblicazione: (2024)